Skip to main content

Table 3 Antibiotic susceptibility by country

From: An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

Antibiotic class

France

Germany

Italy

Spain

United States

Aminoglycosides

141(76.6)

120 (58.3)

101 (75.2)

112 (58.9)

257 (80.2)

Antipseudomonal carbapenems

139 (60.4)

119 (52.1)

107 (57.9)

112 (47.3)

257 (79.0)

Antipseudomonal cephalosporins

140 (77.1)

120 (60.8)

101 (74.3)

111 (59.5)

258 (81.4)

Antipseudomonal fluoroquinolones

138 (66.7)

118 (61.0)

100 (75.0)

111 (52.3)

257 (75.9)

Antipseudomonal penicillins +

141 (64.5)

118 (46.5)

108 (70.3)

110 (63.6)

253 (82.6)

β-lactamase inhibitors

Multidrug-resistant

141 (33.3)

120 (44.2)

108 (22.2)

113 (43.4)

258 (20.5)

Extensively drug-resistant

141 (17.7)

120 (34.2)

108 (2.8)

113 (13.3)

258 (3.5)

  1. Data presented as number of isolates tested (% susceptible). Multidrug-resistant: non-susceptible to one or more agents in three or more antibiotic classes. Extensively drug-resistant: non-susceptible to one or more agents in all but two or fewer antibiotic classes.